HomeNDC LookupRxCUI directory › RxCUI 317573

Pioglitazone 15 MG Oral Tablet — RxCUI 317573

RxNorm drug concept · Semantic clinical drug
RxCUI 317573 Semantic clinical drug · SCD ● Current RxNorm concept 48 FDA products 129 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI317573
Official namePioglitazone 15 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspioglitazone (as pioglitazone hydrochloride) 15 MG Oral Tablet
FDA products mapped48
Package NDCs mapped129
Reported Medicaid activity (SDUD)511,116 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pioglitazone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Pioglitazone helps your body use insulin more effectively — think of it as making your cells more "open" to insulin's signal to absorb blood sugar. It lowers your blood glucose and...
  • What exactly does pioglitazone do for my diabetes?
  • Either way is fine. You can take your tablet with or without food. If you take it with a meal, it may be absorbed a little more slowly, but the total amount your body gets is the s...
  • Do I take this with food or on an empty stomach?
📖 Read our full Pioglitazone guide →

🕸️ Concept Web — How Pioglitazone 15 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Pioglitazone 15 MG Oral Tablet RxCUI 317573

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Pioglitazone 33738
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Actos 261442
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Pioglitazone Oral Tablet 374606
    • Pioglitazone Oral Product 1163231
    • Pioglitazone Pill 1163232
    • Pioglitazone Oral Tablet [Actos] 368230
    • Actos Oral Product 1169928
    • Actos Pill 1169929
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Pioglitazone 15 MG SCDC · 332435
  • Pioglitazone Oral Tablet SCDF · 374606
  • Pioglitazone Oral Product SCDG · 1163231
  • Pioglitazone Pill SCDG · 1163232

Brand-Name Concepts

  • Pioglitazone 15 MG Oral Tablet [Actos] SBD · 261266
  • Pioglitazone 15 MG [Actos] SBDC · 574495
  • Pioglitazone Oral Tablet [Actos] SBDF · 368230
  • Actos Oral Product SBDG · 1169928
  • Actos Pill SBDG · 1169929
  • Actos BN · 261442

📦 FDA Products & Package NDCs

48 products · 129 package NDCs
129 package NDCs map to RxCUI 317573 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50090-6386-01 90 TABLET in 1 BOTTLE (50090-6386-1) PIOGLITAZONE HYDROCHLORIDE A-S Medication Solutions 2023-03-17
57237-0219-05 500 TABLET in 1 BOTTLE (57237-219-05) Pioglitazone Rising Pharma Holdings, Inc. 2013-02-13
57237-0219-30 30 TABLET in 1 BOTTLE (57237-219-30) Pioglitazone Rising Pharma Holdings, Inc. 2013-02-13
57237-0219-90 90 TABLET in 1 BOTTLE (57237-219-90) Pioglitazone Rising Pharma Holdings, Inc. 2019-06-12
57237-0220-05 500 TABLET in 1 BOTTLE (57237-220-05) Pioglitazone Rising Pharma Holdings, Inc. 2013-02-13
57237-0220-30 30 TABLET in 1 BOTTLE (57237-220-30) Pioglitazone Rising Pharma Holdings, Inc. 2013-02-13
57237-0220-90 90 TABLET in 1 BOTTLE (57237-220-90) Pioglitazone Rising Pharma Holdings, Inc. 2019-06-12
57237-0221-05 500 TABLET in 1 BOTTLE (57237-221-05) Pioglitazone Rising Pharma Holdings, Inc. 2013-02-13
57237-0221-30 30 TABLET in 1 BOTTLE (57237-221-30) Pioglitazone Rising Pharma Holdings, Inc. 2013-02-13
57237-0221-90 90 TABLET in 1 BOTTLE (57237-221-90) Pioglitazone Rising Pharma Holdings, Inc. 2013-02-13
60687-0391-01 100 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-391-01) / 1 TAB... Pioglitazone American Health Packaging 2019-06-05
60687-0905-21 30 BLISTER PACK in 1 CARTON (60687-905-21) / 1 TABLET in 1... Pioglitazone American Health Packaging 2026-01-01
62135-0804-30 30 TABLET in 1 BOTTLE (62135-804-30) PIOGLITAZONE HYDROCHLORIDE Chartwell RX, LLC 2024-08-22
62135-0804-90 90 TABLET in 1 BOTTLE (62135-804-90) PIOGLITAZONE HYDROCHLORIDE Chartwell RX, LLC 2024-08-22
62135-0805-30 30 TABLET in 1 BOTTLE (62135-805-30) PIOGLITAZONE HYDROCHLORIDE Chartwell RX, LLC 2024-08-22
62135-0805-90 90 TABLET in 1 BOTTLE (62135-805-90) PIOGLITAZONE HYDROCHLORIDE Chartwell RX, LLC 2024-08-22
62135-0806-30 30 TABLET in 1 BOTTLE (62135-806-30) PIOGLITAZONE HYDROCHLORIDE Chartwell RX, LLC 2024-08-22
62135-0806-90 90 TABLET in 1 BOTTLE (62135-806-90) PIOGLITAZONE HYDROCHLORIDE Chartwell RX, LLC 2024-08-22
64764-0151-02 6 CARTON in 1 TRAY (64764-151-02) / 1 BLISTER PACK in 1 CAR... Actos Takeda Pharmaceuticals America, Inc. 1999-07-15
64764-0151-04 30 TABLET in 1 BOTTLE (64764-151-04) Actos Takeda Pharmaceuticals America, Inc. 1999-07-15
64764-0151-05 90 TABLET in 1 BOTTLE (64764-151-05) Actos Takeda Pharmaceuticals America, Inc. 1999-07-15
64764-0151-06 500 TABLET in 1 BOTTLE (64764-151-06) Actos Takeda Pharmaceuticals America, Inc. 1999-07-15
64764-0301-02 6 CARTON in 1 TRAY (64764-301-02) / 1 BLISTER PACK in 1 CAR... Actos Takeda Pharmaceuticals America, Inc. 1999-07-15
64764-0301-14 30 TABLET in 1 BOTTLE (64764-301-14) Actos Takeda Pharmaceuticals America, Inc. 1999-07-15
64764-0301-15 90 TABLET in 1 BOTTLE (64764-301-15) Actos Takeda Pharmaceuticals America, Inc. 1999-07-15
64764-0301-16 500 TABLET in 1 BOTTLE (64764-301-16) Actos Takeda Pharmaceuticals America, Inc. 1999-07-15
64764-0451-02 6 CARTON in 1 TRAY (64764-451-02) / 1 BLISTER PACK in 1 CAR... Actos Takeda Pharmaceuticals America, Inc. 1999-07-15
64764-0451-24 30 TABLET in 1 BOTTLE (64764-451-24) Actos Takeda Pharmaceuticals America, Inc. 1999-07-15
64764-0451-25 90 TABLET in 1 BOTTLE (64764-451-25) Actos Takeda Pharmaceuticals America, Inc. 1999-07-15
64764-0451-26 500 TABLET in 1 BOTTLE (64764-451-26) Actos Takeda Pharmaceuticals America, Inc. 1999-07-15
65862-0512-05 500 TABLET in 1 BOTTLE (65862-512-05) PIOGLITAZONE HYDROCHLORIDE Aurobindo Pharma Limited 2013-02-13
65862-0512-10 3 BLISTER PACK in 1 CARTON (65862-512-10) / 10 TABLET in 1... PIOGLITAZONE HYDROCHLORIDE Aurobindo Pharma Limited 2013-02-13
65862-0512-30 30 TABLET in 1 BOTTLE (65862-512-30) PIOGLITAZONE HYDROCHLORIDE Aurobindo Pharma Limited 2013-02-13
65862-0512-90 90 TABLET in 1 BOTTLE (65862-512-90) PIOGLITAZONE HYDROCHLORIDE Aurobindo Pharma Limited 2019-06-14
65862-0513-05 500 TABLET in 1 BOTTLE (65862-513-05) PIOGLITAZONE HYDROCHLORIDE Aurobindo Pharma Limited 2013-02-13
65862-0513-10 3 BLISTER PACK in 1 CARTON (65862-513-10) / 10 TABLET in 1... PIOGLITAZONE HYDROCHLORIDE Aurobindo Pharma Limited 2013-02-13
65862-0513-30 30 TABLET in 1 BOTTLE (65862-513-30) PIOGLITAZONE HYDROCHLORIDE Aurobindo Pharma Limited 2013-02-13
65862-0513-90 90 TABLET in 1 BOTTLE (65862-513-90) PIOGLITAZONE HYDROCHLORIDE Aurobindo Pharma Limited 2019-06-14
65862-0514-05 500 TABLET in 1 BOTTLE (65862-514-05) PIOGLITAZONE HYDROCHLORIDE Aurobindo Pharma Limited 2013-02-13
65862-0514-10 3 BLISTER PACK in 1 CARTON (65862-514-10) / 10 TABLET in 1... PIOGLITAZONE HYDROCHLORIDE Aurobindo Pharma Limited 2013-02-13
65862-0514-30 30 TABLET in 1 BOTTLE (65862-514-30) PIOGLITAZONE HYDROCHLORIDE Aurobindo Pharma Limited 2013-02-13
65862-0514-90 90 TABLET in 1 BOTTLE (65862-514-90) PIOGLITAZONE HYDROCHLORIDE Aurobindo Pharma Limited 2013-02-13
68071-5199-03 30 TABLET in 1 BOTTLE (68071-5199-3) Pioglitazone NuCare Pharmaceuticals,Inc. 2020-03-10
68071-5245-03 30 TABLET in 1 BOTTLE (68071-5245-3) Pioglitazone NuCare Pharmaceuticals,Inc. 2020-04-29
68788-7511-01 100 TABLET in 1 BOTTLE (68788-7511-1) Pioglitazone Preferred Pharmaceuticals, Inc. 2019-12-27
68788-7511-03 30 TABLET in 1 BOTTLE (68788-7511-3) Pioglitazone Preferred Pharmaceuticals, Inc. 2019-12-27
68788-7511-06 60 TABLET in 1 BOTTLE (68788-7511-6) Pioglitazone Preferred Pharmaceuticals, Inc. 2019-12-27
68788-7511-09 90 TABLET in 1 BOTTLE (68788-7511-9) Pioglitazone Preferred Pharmaceuticals, Inc. 2019-12-27
70518-2609-00 90 TABLET in 1 BOTTLE, PLASTIC (70518-2609-0) Pioglitazone REMEDYREPACK INC. 2020-03-02
71335-1343-01 30 TABLET in 1 BOTTLE (71335-1343-1) Pioglitazone Bryant Ranch Prepack 2019-09-11
Observed labelers: Aurobindo Pharma Limited (12) · Macleods Pharmaceuticals Limited (12) · Takeda Pharmaceuticals America, Inc. (12) · Unichem Pharmaceuticals (USA), Inc. (12) · GSMS, Incorporated (9) · NorthStar RxLLC (9) · +14 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.